Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)
Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The primary goal of this study is to determine the clinical advantage of pre-treatment with
mifepristone in second trimester misoprostol induction abortion. This will be a randomized
controlled double-blinded trial of 20 women comparing misoprostol alone to mifepristone plus
misoprostol for second trimester (14-21 weeks' LMP) medical abortion.